Position in PRGO
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$144,930
New position
Shares Held
13,949
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#208
of 334 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $5,747,253 across 11 Drug Manufacturers - Specialty & Generic names. PRGO ranks #11 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
19,404 | $1,394,371 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,054 | $1,085,989 | |
| 3 | VTRS |
Viatris Inc
|
44,259 | $702,832 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
12,842 | $464,880 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
27,496 | $440,760 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
24,898 | $360,772 | |
| 7 | HLN |
Haleon plc
|
38,318 | $357,506 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
534 | $289,337 |
All Filings in PRGO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,930 | 13,949 | Shares | Defined | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||